MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517049519 A) filed by Ablexis, Llc, San Diego, on May 22, for 'anti-cd3 antibodies.'
Inventor(s) include Rainey, Godfrey Jonah; Seagal, Jane; and Akoopie, Arvin.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure provides anti-CD3 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic and diagnostic methods for the treatment of diseases and disorders, such as cancer and autoimmune diseases and disorders. The present disclosure also relates to bispecific antibodies comprising an...